BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 31, 2016
View Archived Issues
Fostamatinib meets primary endpoint in the first study from the FIT phase III clinical program
Read More
NIAID awards grant to Hawaii Biotech for chikungunya virus vaccine research
Read More
FDA approves Afluria Quadrivalent influenza vaccine for people 18 years of age and older
Read More
FDA approves biosimilar etanercept Erelzi
Read More
Oblato's disufenton sodium receives FDA orphan drug designation
Read More
OPKO Health completes Transition Therapeutics acquisition
Read More
Merck Patent discloses NUDT1 inhibitors
Read More
Nanjing Gator Meditech and Jilin University patent PI3Kdelta inhibitors
Read More
Ningbo Wenda Pharmaceutical Technology develops EGFR inhibitors
Read More
FDA accepts NDA for edaravone in ALS
Read More
Yissum Research Development reports anticancer agents
Read More
Ariad completes rolling NDA submission for brigatinib
Read More
Sunshine Lake Pharma describes FXR agonists
Read More
Nymox's fexapotide shows clinically meaningful benefits in BPH
Read More
rAAV6-INT41 intrabody therapy shows promise in vivo for Huntington's disease
Read More
Debiopharm invests in start-up diagnostics company GenePOC
Read More
Merck KGaA discovers potent and selective inhibitors of the kinase GCN2
Read More
FDA accepts BLA for CSL-830
Read More
GlaxoSmithKline tests novel antimalarial quinazolindiones
Read More
ONO Pharmaceutical develops GABA(A) alpha-5 negative allosteric modulators
Read More
FDA responts to Oragenic's request for type C meeting
Read More
Valeant will commercialize Contrave in Canada under an agreement with Orexigen
Read More
DNA methylation-based assay significantly improves diagnosis of cancer of unknown primary
Read More
Kamada reports positive results on inhaled alpha-1 antitrypsin phase II trial
Read More
Arbutus Biopharma terminates exclusive license agreement with Kuros Biosciences
Read More
Novel desmin mutation causes left-dominant arrhythmogenic cardiomyopathy
Read More
FDA grants orphan drug designation to Genentech's etrolizumab
Read More